Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment… Read more






![Chemical structure of rel-(3aR,9aS)-2,2-Dimethyl-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-5-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F52187-19-6-rel-3aR9aS-22-Dimethyl-3a499a-tetrahydronaphtho23-d13dioxol-5-ol.png&w=3840&q=75)
![Chemical structure of rel-(3aR,9aS)-2,2-Dimethyl-3a,4,9,9a-tetrahydronaphtho[2,3-d][1,3]dioxol-5-yl acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2256724-57-7-rel-3aR9aS-22-Dimethyl-3a499a-tetrahydronaphtho23-d13dioxol-5-yl-acetate.png&w=3840&q=75)

Nadolol is a non-selective beta-blocker indicated for the management of hypertension and the long-term treatment of angina pectoris, with further clinical applications in migraine prophylaxis and the treatment of cirrhosis complications. Laboratories rely on this category of high-quality reference standards, which encompasses the Nadolol active pharmaceutical ingredient (API), its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for rigorous impurity profiling, method validation, and ongoing quality control protocols. By utilizing well-characterized reference standards and isotopically labelled analogs, analytical chemists can ensure the accuracy and reliability of chromatographic testing and quantification processes throughout the pharmaceutical product lifecycle.